Cargando…

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response

Early biomarkers of therapeutic responses can help optimize the treatment of metastatic colorectal cancers (mCRC). In this prospective exploratory study, we examined serial changes of plasma-circulating tumor DNA (ctDNA) in 41 mCRC patients receiving first-line chemotherapies and tested its associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Ning, Sun, Zhao, Gao, Xin, Cheng, Yuejuan, Zhou, Yanping, Shen, Chunying, Chen, Wei, Wang, Xueliang, Shi, Rong, Li, Nan, Zhou, Jianfeng, Bai, Chunmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536571/ https://www.ncbi.nlm.nih.gov/pubmed/31164904 http://dx.doi.org/10.3389/fgene.2019.00470

Ejemplares similares

Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer
por: Jia, Ning, et al.
Publicado: (2021)

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
por: Reece, Mifanwy, et al.
Publicado: (2019)

The Circular RNA Profiles of Colorectal Tumor Metastatic Cells
por: Jiang, Weiqin, et al.
Publicado: (2018)

Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signature
por: Zhou, Xueliang, et al.
Publicado: (2022)

Identification of Autophagy-Related LncRNA to Predict the Prognosis of Colorectal Cancer
por: Duan, Ling, et al.
Publicado: (2022)

Systemic treatment of a metastatic carotid body tumor: A case report and literature review
por: Xing, Jiazhang, et al.
Publicado: (2020)

Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
por: Gao, Wei, et al.
Publicado: (2021)

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
por: Olsson, Eleonor, et al.
Publicado: (2015)

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer
por: Chin, Yoon Ming, et al.
Publicado: (2022)

MICA (∗)012:01 Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer
por: Ding, Weifeng, et al.
Publicado: (2020)

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
por: Yao, Yunjin, et al.
Publicado: (2021)

Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer
por: Zocche, David M., et al.
Publicado: (2015)

A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer
por: Hou, Dong, et al.
Publicado: (2022)

KDR Mutation as a Novel Predictive Biomarker of Exceptional Response to Regorafenib in Metastatic Colorectal Cancer
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2016)

Circulating tumor DNA applications in monitoring the treatment of metastatic colorectal cancer patients
por: Kazemifard, Nesa, et al.
Publicado: (2019)

Implications of microRNAs in Colorectal Cancer Development, Diagnosis, Prognosis, and Therapeutics
por: Zhai, Haiyan, et al.
Publicado: (2011)

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
por: Zhou, Xinping, et al.
Publicado: (2023)

Identification of a novel lipid metabolism-related gene signature for predicting colorectal cancer survival
por: Huang, Yanpeng, et al.
Publicado: (2022)

Detection of circulating microRNAs with Ago2 complexes to monitor the tumor dynamics of colorectal cancer patients during chemotherapy
por: Fuji, Tomokazu, et al.
Publicado: (2019)

Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
por: Miranda, E, et al.
Publicado: (2006)

Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model
por: Ma, Chao, et al.
Publicado: (2021)

Emerging Role and Mechanism of circRNAs in Pediatric Malignant Solid Tumors
por: Shen, Qiyang, et al.
Publicado: (2022)

DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer
por: Zeng, Yunqing, et al.
Publicado: (2022)

Circulating microRNAs in Response to Exercise Training in Healthy Adults
por: Zhou, Qiulian, et al.
Publicado: (2020)

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response
por: Liu, Jialing, et al.
Publicado: (2021)

Circulating Tumor DNA Response and Minimal Residual Disease Assessment in DNA Polymerase Epsilon-Mutated Colorectal Cancer Undergoing Immunotherapy
por: Lutfi, Areeb, et al.
Publicado: (2023)

Circulating adipokine levels and preeclampsia: A bidirectional Mendelian randomization study
por: Chen, Xiaoyan, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic Targets
por: Qu, Yi-Yuan, et al.
Publicado: (2021)

SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma
por: Zhou, Quanwei, et al.
Publicado: (2022)

FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis
por: Zhang, Yiyi, et al.
Publicado: (2020)

Association Between Circulating Linoleic Acid and Risk of Ischemic Stroke
por: Ye, Ding, et al.
Publicado: (2021)

Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer
por: Lin, Xu-tao, et al.
Publicado: (2021)

Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study
por: Wang, Xicheng, et al.
Publicado: (2020)

Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Zhu, Chunmei, et al.
Publicado: (2022)

Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma
por: Thomsen, C. B., et al.
Publicado: (2018)

Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma
por: Liang, Wenjin, et al.
Publicado: (2022)

Association of cardiovascular risk factors and lifestyle behaviors with aortic aneurysm: A Mendelian randomization study
por: Zhou, Jiawei, et al.
Publicado: (2022)

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma
por: Tang, Hui, et al.
Publicado: (2023)

The Crosstalk Between Immune Infiltration, Circulating Tumor Cells, and Metastasis in Pancreatic Cancer: Identification of HMGB3 From a Multiple Omics Analysis
por: Tang, Hao-dong, et al.
Publicado: (2022)

A Novel Six-Gene-Based Prognostic Model Predicts Survival and Clinical Risk Score for Gastric Cancer
por: Li, Juan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5d7vg9us2cduvq7hscqva2ioak